DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Press-release

Pharmacia and Pfizer's Celebrex and Merck's Vioxx Will Soon Compete with Second-Generation Selective COX-2 Inhibitors in the Osteoarthritis Drug Market, According to a Decision Resources Study

Pharmacia and Pfizer's Celebrex and Merck's Vioxx Will Soon Compete with Second-Generation Selective COX-2 Inhibitors in the Osteoarthritis Drug Market, According to a Decision Resources Study

All eyes have been on the first selective COX-2 inhibitors, celecoxib (Pharmacia and Pfizer's Celebrex) and rofecoxib (Merck's Vioxx), for the...

READ ARTICLE

Press-release

Decision Resources Study Evaluates Type 2 Diabetes Therapies in Early- and Late-Stage Development and Forecasts Their Commercial Potential

Decision Resources Study Evaluates Type 2 Diabetes Therapies in Early- and Late-Stage Development and Forecasts Their Commercial Potential

Decision Resources, Inc., announces the publication of Type 2 Diabetes, a new study that evaluates the commercial potential of novel agents to treat...

READ ARTICLE

Press-release

Decision Resources Study Examines Improvements in Diagnostic Technologies and Clinical Trial Design that May Lead to More-Effective Acute Ischemic Stroke Therapies

Decision Resources Study Examines Improvements in Diagnostic Technologies and Clinical Trial Design that May Lead to More-Effective Acute Ischemic Stroke Therapies

Acute Ischemic Stroke is a new study from Decision Resources, Inc., that examines the significant unmet needs in the management of ischemic stroke (IS...

READ ARTICLE

Press-release

Decision Resources Elects Two Vice Presidents

Decision Resources Elects Two Vice Presidents

Decision Resources, Inc., a pharmaceutical research and consulting firm, is pleased to announce the election of two new Vice Presidents-James...

READ ARTICLE

Press-release

Emerging Agents with Anticoagulant and Anti-Inflammatory Properties Promise Safe, Effective Treatments for Severe Sepsis and Septic Shock, According to a Decision Resources Study

Emerging Agents with Anticoagulant and Anti-Inflammatory Properties Promise Safe, Effective Treatments for Severe Sepsis and Septic Shock, According to a Decision Resources Study

Sepsis and septic shock are leading causes of morbidity and mortality among hospitalized patients. Sepsis and Septic Shock is a new study from...

READ ARTICLE

Press-release

Decision Resources Report Identifies Opportunities Generated by Trends in Genomics Dealmaking

Decision Resources Report Identifies Opportunities Generated by Trends in Genomics Dealmaking

Decision Resources, Inc., announces the publication of Genomics Dealmaking in 2000 and Future Outlook: Bioinformatics, Gene Expression Monitoring,...

READ ARTICLE

Press-release

Decision Resources Study on Post-Myocardial Infarction Finds AstraZeneca's Rosuvastatin May Become the Statin of Choice by 2005

Decision Resources Study on Post-Myocardial Infarction Finds AstraZeneca's Rosuvastatin May Become the Statin of Choice by 2005

Post-Myocardial Infarction is a new study from Decision Resources, Inc., that examines how the need for better and novel cardioprotective agents to...

READ ARTICLE

Press-release

Novel Asthma Therapies and Combination Agents Will Vie for Market Share, According to a Decision Resources Study

Novel Asthma Therapies and Combination Agents Will Vie for Market Share, According to a Decision Resources Study

Asthma is a new Decision Resources study that examines novel drug development efforts arising from a wealth of research into the pathophysiology of...

READ ARTICLE